FDA to Review Topical Psoriasis Treatment for Young Children
Roflumilast cream 0.3% was approved for treating psoriasis in adolescents and adults in July.
Source: medscape.com
Stay updated with breaking news from Maximal Usage Systemic Exposure. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roflumilast cream 0.3% was approved for treating psoriasis in adolescents and adults in July.